4SC | resminostat | Oncology |
4SC | vidofludimus | Immunology |
ABBOTT LABORATORIES | enavatuzumab | Oncology |
ABBVIE | aganepag | Ophthalmology |
ABBVIE | simenepag | Ophthalmology |
ABBVIE | cenicriviroc | Antiviral |
ABBVIE | elotuzumab | Oncology |
ABBVIE | navitoclax | Oncology |
ABBVIE | rezatomidine | Pain & Inflammation |
ABBVIE | valproate | Neurology |
ABBVIE | linifanib | Oncology |
ABBVIE | veliparib | Oncology |
ABBVIE | ceftaroline fosamil | Antibiotic |
ABBVIE | senrebotase | Pain & Inflammation |
ABBVIE | ilorasertib | Oncology |
ABBVIE | abicipar pegol | Ophthalmology |
ABBVIE | eluxadoline | Gastrointestinal |
ABBVIE | dasabuvir | Antiviral |
ABBVIE | ombitasvir | Antiviral |
ABBVIE | rapastinel | Neurology |
ABBVIE | acorafloxacin | Antibiotic |
ABBVIE | modimelanotide | Urology |
ABBVIE | paritaprevir | Antiviral/HIV |
ABBVIE | venetoclax | Oncology |
ABBVIE | glecaprevir | Antiviral |
ABBVIE | nelonicline | Neurology |
ABBVIE | pibrentasvir | Antiviral |
ABBVIE | rovalpituzumab | Oncology |
ABBVIE | rovalpituzumab tesirine | Oncology |
ABBVIE | apimostinel | Neurology |
ABBVIE | alicapistat | Neurology |
ABBVIE | depatuxizumab | Oncology |
ABBVIE | depatuxizumab mafodotin | Oncology |
ABBVIE | elezanumab | Neurology |
ABBVIE | flurdihydroergotamine | Pain & Inflammation |
ABBVIE | telisotuzumab | Oncology |
ABBVIE | telisotuzumab vedotin | Oncology |
ABBVIE | atogepant | Pain & Inflammation |
ABBVIE | azintuxizumab | Oncology |
ABBVIE | azintuxizumab vedotin | Oncology |
ABBVIE | benzodrocortisone | Ophthalmology |
ABBVIE | rizankizumab | Oncology |
ABBVIE | revosimeline | Neurology |
ABBVIE | samrotamab | Oncology |
ABBVIE | samrotamab vedotin | Oncology |
ABBVIE | budigalimab | Oncology |
ABBVIE | dilpacimab | Cardiovascular |
ABBVIE | eftozanermin alfa | Oncology |
ABBVIE | galicaftor | Respiratory |
ABBVIE | rolinsatamab | Oncology |
ABBVIE | rolinsatamab talirine | Oncology |
ABBVIE | vimirogant | Dermatology |
ABBVIE | foscarbidopa | Neurology |
ABBVIE | foslevodopa | Neurology |
ABBVIE | serclutamab | Oncology |
ABBVIE | serclutamab talirine | Oncology |
ABBVIE | tamrintamab | Oncology |
ABBVIE | tamrintamab pamozirineab | Oncology |
ABBVIE | tilavonemab | Neurology |
ABBVIE | nivobotulinumtoxina | Dermatology |
ABBVIE | risankizumab-rzaa | Biologic Suffix |
ABBVIE | giloralimab | Oncology |
ABBVIE | revdofilimab | Oncology |
ABBVIE | zelquistinel | Neurology |
ABBVIE | cedirogant | Oncology |
ABBVIE | flubentylosin | Ophthalmology |
ABBVIE | mirzotamab | Oncology |
ABBVIE | mirzotamab clezutoclax | Oncology |
ABBVIE | elsubrutinib | Pain & Inflammation |
ABBVIE | navocaftor | Respiratory |
ABEONA | prademagene zamikeracel | Dermatology |
ABEONA | rebisufligene etisparvovec | Metabolic Disorders |
ACCERA | tricaprillin | Neurology |
ACERTA PHARMA | acalabrutinib | Oncology |
ACETYLON | ricolinostat | Oncology |
ACHAOGEN | plazomicin sulfate | Antibiotic |
ACHAOGEN | plazomicin | Antibiotic |
ACHILLION | odalasvir | Antiviral/HIV |
ACHILLION | danicopan | Hematology |
ACLARIS THERAPEUTICS | ifidancitinib | Neurology |
ACLARIS THERAPEUTICS | fosifidancitinib | Neurology |
ACORDA THERAPEUTICS | cimaglermin alfa | Cardiovascular |
ACTICOR BIOTECH | glenzocimab | Cardiovascular |
ACTINIUM | iodine (131i) apamistamab | Oncology |
ACTINIUM | actinium (225ac) lintuzumab satetraxetan | Oncology |
ACTOBIO | dapatifagene navolactibac | Pain & Inflammation |
ADAPTIMMUNE | afamitresgene autoleucel | Oncology |
ADAPTIMMUNE | afamitresgene autoleucel | Oncology |
ADAPTIMMUNE | letetresgene autoleucel | Oncology |
ADAPTIMMUNE | olitresgene autoleucel | Oncology |
ADC THERAPEUTICS | mipasetamab | Oncology |
ADC THERAPEUTICS | mipasetamab uzoptirine | Oncology |
ADC THERAPEUTICS | camidanlumab | Oncology |
ADC THERAPEUTICS | camidanlumab tesirine | Oncology |
ADC THERAPEUTICS | loncastuximab | Oncology |
ADC THERAPEUTICS | loncastuximab tesirine | Oncology |
ADRENOMED | enibarcimab | Cardiovascular |
ADVAXIS | capolimogene apralisbac | Oncology |
ADVAXIS | axalimogene filolisbac | Oncology |
ADYNXX | brivoligide | Pain & Inflammation |
AEGLEA BIOTHERAPEUTICS | pegzilarginase | Metabolic Disorders |
AERPIO | razuprotafib | Ophthalmology |
AFFIBODY | tezatabep matraxetan | Oncology |
AFFIBODY | tifalibep | Immunology |
AFFIBODY | izokibep | Dermatology |
AFFYMAX | peginesatide | Hematology |
AGENUS | zalifrelimab | Immunology |
AGIOS | vorasidenib citrate | Oncology |
AGIOS | mitapivat | Metabolic Disorders |
AGIOS | vorasidenib | Oncology |
AGIOS | ivosidenib | Oncology |
AGIOS | enasidenib | Oncology |
AILERON THERAPEUTICS | sulanemadlin | Oncology |
AIMMUNE | peanut (arachis hypogaea) allergen powder-dnfp | Biologic Suffix |
ALBA THERAPEUTICS | larazotide acetate | Immunology |
ALBA THERAPEUTICS | larazotide | Immunology |
ALBIREO | odevixibat | Metabolic Disorders |
ALCON | guaraprolose | Ophthalmology |
ALCON | tesidolumab | Ophthalmology |
ALCON | brolucizumab | Ophthalmology |
ALCON | indimilast | Ophthalmology |
ALCON | lavamilast | Immunology |
ALCON | acrizanib | Ophthalmology |
ALEXION PHARMACEUTICALS | cerdulatinib | Oncology |
ALEXION PHARMACEUTICALS | andexanet alfa | Hematology |
ALEXION PHARMACEUTICALS | coagulation factor xa (recombinant), inactivated-zhzo | Biologic Suffix |
ALKERMES | nemvaleukin alfa | Oncology |
ALKERMES | diroximel fumarate | Neurology |
ALLENA PHARMACEUTICALS | reloxaliase | Nephrology |
ALTUS PHARMACEUTICALS | liprotamase | Immunology |
ALZPROTECT | ezeprogind | Neurology |
AMGEN | murizatoclax | Oncology |
AMGEN | rozibafusp alfa | Immunology |
AMGEN | azelaprag | Cardiovascular |
AMGEN | efavaleukin alfa | Immunology |
AMGEN | acapatamab | Oncology |
AMGEN | eluvixtamab | Oncology |
AMGEN | emerfetamab | Oncology |
AMGEN | etevritamab | Oncology |
AMGEN | pacanalotamab | Oncology |
AMGEN | pavurutamab | Oncology |
AMGEN | sotorasib | Oncology |
AMGEN | tarlatamab | Oncology |
AMGEN | olpasiran | Cardiovascular |
AMGEN | zelminemab | Neurology |
AMGEN | tapotoclax | Oncology |
AMGEN | vidupiprant | Respiratory |
AMGEN | evolocumab | Cardiovascular |
AMGEN | romosozumab | Musculoskeletal |
AMGEN | trebananib | Oncology |
AMGEN | brodalumab | Immunology |
AMGEN | oprozomib | Oncology |
AMGEN | bevacizumab beta | Oncology |
AMGEN | prezalumab | Immunology |
AMORE PACIFIC | asivatrep | Dermatology |
AMPLYX | fosmanogepix | Antifungal |
ANADYS | setrobuvir | Antiviral |
ANGION | terevalefim | Nephrology |
ANHEART THERAPEUTICS | taletrectinib | Oncology |
ANTIBE THERAPEUTICS | otenaproxesul | Pain & Inflammation |
APEIRON | lorukafusp alfa | Oncology |
APELLIS | pegcetacoplan | Hematology |
APOPHARMA | deferiprone | Hematology |
APOTEX | cyclosporine | Ophthalmology |
APOTEX | docetaxel | Oncology |
APREA | eprenetapopt | Oncology |
AQUINOX PHARMACEUTICALS | rosiptor acetate | Pain & Inflammation |
AQUINOX PHARMACEUTICALS | rosiptor | Pain & Inflammation |
ARAIM PHARMACEUTICALS | cibinetide | Pain & Inflammation |
ARCHEMIX | egaptivon pegol | Hematology |
ARCUS | zimberelimab | Oncology |
ARDEA BIOSCIENCES | verinurad | Endocrinology |
ARDELYX | tenapanor | Gastrointestinal |
ARIAD | ponatinib | Oncology |
ARIAD | ponatinib hydrochloride | Oncology |
ARIVIVE | batiraxcept | Oncology |
ARQULE | vevorisertib | Oncology |
ARQULE | derazantinib hydrochloride | Oncology |
ARQULE | derazantinib | Oncology |
ARQULE | miransertib | Oncology |
ARSANIS | atidortoxumab | Antibiotic |
ARSANIS | berlimatoxumab | Antibiotic |
ASARINA PHARMA | sepranolone | Women's Health |
ASCENDIS PHARMA | lonapegsomatropin | Metabolic Disorders |
ASCENTAGE PHARMA | pelcitoclax | Oncology |
ASSEMBLY BIO | vebicorvir | Antiviral |
ASTELLAS | gilteritinib | Oncology |
ASTELLAS | zolbetuximab | Oncology |
ASTELLAS | vernakalant | Cardiovascular |
ASTEX | guadecitabine | Oncology |
ASTEX | cedazuridine | Oncology |
ASTRAZENECA | telratolimod | Oncology |
ASTRAZENECA | ceralasertib | Oncology |
ASTRAZENECA | verdiperstat | Neurology |
ASTRAZENECA | velsecorat | Respiratory |
ASTRAZENECA | navafenterol | Respiratory |
ASTRAZENECA | savolitinib | Oncology |
ASTRAZENECA | acalabrutinib | Oncology |
ASTRAZENECA | adavosertib | Oncology |
ASTRAZENECA | capivasertib | Oncology |
ASTRAZENECA | danvatirsen | Oncology |
ASTRAZENECA | bicalutamide | Oncology |
ASTRAZENECA | rosuvastatin calcium | Cardiovascular |
ASTRAZENECA | selumetinib | Oncology |
ASTRAZENECA | avibactam | Antibiotic |
ASTRAZENECA | selumetinib sulfate | Oncology |
ASTRAZENECA | naloxegol | Gastrointestinal |
ASTRAZENECA | dexmecamylamine | Neurology |
ATHENEX | tirbanibulin | Oncology |
ATHENEX | encequidar | Oncology |
ATHERSYS | invimestrocel | Cardiovascular |
ATOX BIO | reltecimod | Immunology |
AURA BIOSCIENCES | belzupacap sarotalocan | Ophthalmology |
AURINIA | terameprocol | Oncology |
AURINIA | voclosporin | Immunology |
AUTOLUS | obecabtagene autoleucel | Oncology |
AUVEN | navamepent | Ophthalmology |
AVANIR PHARMACEUTICALS | deudextromethorphan | Neurology |
AVELAS BIOSCIENCES | pegloprastide | Oncology |
AVERA PHARMACEUTICALS | gantacurium | Respiratory |
AVEXIS | onasemnogene abeparvovec | Neurology |
AVEXIS | onasemnogene abeparvovec-xioi | Biologic Suffix |
AVIRAGEN THERAPEUTICS | teslexivir | Antiviral |
AVIRAGEN THERAPEUTICS | enzaplatovir | Antiviral |
AVIRAGEN THERAPEUTICS | vapendavir | Antiviral |
BASF AGRICULTURE | icosabutate | Metabolic Disorders |
BASILEA PHARMACEUTICA | lisavanbulin | Oncology |
BASILEA PHARMACEUTICA | avanbulin | Oncology |
BAUSCH & LOMB | latanoprostene bunod | Ophthalmology |
BAUSCH & LOMB | besifloxacin | Ophthalmology |
BAUSCH & LOMB | efinaconazole | Antifungal |
BAUSCH HEALTH | pradefovir | Antiviral |
BAUSCH HEALTH | taribavirin | Antiviral |
BAUSCH HEALTH | tenofovir | Antiviral/HIV |
BAUSCH HEALTH | vabavine | Antiviral/HIV |
BAXTER | atilmotin | Gastrointestinal |
BAYER | sorafenib | Oncology |
BAYER | radretumab | Oncology |
BAYER | copanlisib | Oncology |
BAYER | refametinib | Oncology |
BAYER | roniciclib | Oncology |
BAYER | oreptacog alfa | Hematology |
BAYER | darolutamide | Oncology |
BAYER | aprutumab | Oncology |
BAYER | aprutumab ixadotin | Oncology |
BAYER | atihemophilic factor (recombinant), pegylated-aucl | Biologic Suffix |
BEIGENE | garivulimab | Oncology |
BEIGENE | ociperlimab | Oncology |
BEIGENE | lifirafenib | Oncology |
BEIGENE | pamiparib | Oncology |
BEIGENE | tislelizumab | Oncology |
BEIGENE | zanubrutinib | Oncology |
BELLICUM PHARMACEUTICALS | rivogenlecleucel | Immunology |
BELLICUM PHARMACEUTICALS | rimiducid | Oncology |
BERGEN BIO | bemcentinib | Oncology |
BERGEN BIO | tilvestamab | Oncology |
BETA PHARMA | rezivertinib | Oncology |
BETACAT | tegavivint | Oncology |
BEYONDBIO | avotaciclib | Oncology |
BIO-PATH HOLDINGS | prexigebersen | Oncology |
BIOCANCELL THERAPEUTICS | inodiftagene vixteplasmid | Oncology |
BIOCRYST | berotralstat | Pain & Inflammation |
BIOCRYST | galidesivir | Antiviral |
BIOCRYST | avoralstat | Pain & Inflammation |
BIOCRYST | ulodesine | Pain & Inflammation |
BIOINVENT INTERNATIONAL | bersanlimab | Oncology |
BIOLINE RX | motixafortide | Oncology |
BIOMARIN | pegvaliase-pqpz | Biologic Suffix |
BIOMARIN | elosulfase alfa | Immunology |
BIOMARIN | reveglucosidase alfa | Metabolic Disorders |
BIOMARIN | pegvaliase | Metabolic Disorders |
BIOMARIN | cerliponase alfa | Neurology |
BIOMARIN | vosoritide | Musculoskeletal |
BIOMARIN | tralesinidase alfa | Metabolic Disorders |
BIOMARIN | dematersen | Musculoskeletal |
BIOMARIN | rimigorsen | Musculoskeletal |
BIOMARIN | valoctocogene roxaparvovec | Hematology |
BIOMARIN | varodarsen | Musculoskeletal |
BIOMED VALLEY | ulixertinib | Oncology |
BIONOVUS LIFE SCIENCES | fosciclopirox | Oncology |
BIONTECH | enomimeran | Immunology |
BIONTECH | gindameran | Immunology |
BIONTECH | ontasameran | Immunology |
BIONTECH | vibosameran | Immunology |
BIONTECH | tozinameran | Antiviral |
BIOSIGHT | aspacytarabine | Oncology |
BIOVERATIV | efanesoctocog alfa | Hematology |
BIPAR | iniparib | Oncology |
BLAZE BIOSCIENCE | tozuleristide | Oncology |
BLUE EARTH DIAGNOSTICS | flotufolastat (18f) | Oncology |
BLUEBIRD BIO | elivaldogene autotemcel | Hematology |
BLUEBIRD BIO | betibeglogene autotemcel | Neurology |
BLUEBIRD BIO | elivaldogene tavalentivec | Neurology |
BLUEBIRD BIO | betibeglogene darolentivec | Hematology |
BLUEPRINT MEDICINES | avapritinib | Oncology |
BLUEPRINT MEDICINES | pralsetinib | Oncology |
BLUEPRINT MEDICINES | fisogatinib | Oncology |
BOSTON PHARMACEUTICALS | avizakimab | Immunology |
BOSTON PHARMACEUTICALS | ancremonam | Antibiotic |
BRISTOL MYERS SQUIBB | onatasertib | Oncology |
BRISTOL MYERS SQUIBB | orvacabtagene autoleucel | Oncology |
BRISTOL MYERS SQUIBB | cendakimab | Pain & Inflammation |
BRISTOL MYERS SQUIBB | onatasertib | Oncology |
BRISTOL MYERS SQUIBB | danicamtiv | Cardiovascular |
BRISTOL MYERS SQUIBB | vadacabtagene leraleucel | Oncology |
BRISTOL MYERS SQUIBB | cimlanod | Cardiovascular |
BRISTOL MYERS SQUIBB | mavacamten | Cardiovascular |
BRISTOL MYERS SQUIBB | cenplacel | Gastrointestinal |
BRISTOL MYERS SQUIBB | vadacabtagene leraleucel | Oncology |
BRISTOL MYERS SQUIBB | tanespimycin | Oncology |
BRISTOL MYERS SQUIBB | apremilast | Pain & Inflammation |
BRISTOL MYERS SQUIBB | pomalidomide | Oncology |
BRISTOL MYERS SQUIBB | alvespimycin | Oncology |
BRISTOL MYERS SQUIBB | alvespimycin hydrochloride | Oncology |
BRISTOL MYERS SQUIBB | amrubicin hydrochloride | Oncology |
CADENT THERAPEUTICS | rimtuzalcap | Neurology |
CALITHERA | telaglenastat | Oncology |
CAN-FITE BIOPHARMA | namodenoson | Pain & Inflammation |
CAN-FITE BIOPHARMA | piclidenoson | Pain & Inflammation |
CANTEX PHARMACEUTICALS | dociparstat | Oncology |
CATABASIS PHARMACEUTICALS | edasalonexent | Metabolic Disorders |
CATABASIS PHARMACEUTICALS | nicodicosapent | Metabolic Disorders |
CATALYST BIOSCIENCES | dalcinonacog alfa | Hematology |
CELLID | vibapapogene autoleucel | Oncology |
CELLTRION HEALTHCARE | trastuzumab-pkrb | Biologic Suffix |
CELLTRION HEALTHCARE | rituximab-abbs | Biologic Suffix |
CENTREXION | capsaicin | Pain & Inflammation |
CERECOR | rislenemdaz | Neurology |
CERECOR | aticaprant | Neurology |
CERESPIR | itanapraced | Neurology |
CEREVEL | darigabat | Neurology |
CERULEAN | davamotecan pegadexamer | Oncology |
CHECKMATE | vidutolimod | Immunology |
CHECKPOINT THERAPEUTICS | olafertinib | Oncology |
CHECKPOINT THERAPEUTICS | cosibelimab | Oncology |
CHEMOCENTRYX | ilacirnon | Nephrology |
CHEMOCENTRYX | avacopan | Immunology |
CHIMERIX | brincidofovir | Antiviral |
CHINOOK THERAPEUTICS | miralimogene ensolisbac | Immunology |
CHINOOK THERAPEUTICS | damistimagene matitucel | Oncology |
CHINOOK THERAPEUTICS | enistimagene setitucel | Oncology |
CHONG KUN DANG | alteminostat | Oncology |
CHONG KUN DANG | valecobulin | Oncology |
CHONG KUN DANG | rocacetrapib | Endocrinology |
CIDARA THERAPEUTICS | rezafungin | Antibiotic |
CIDARA THERAPEUTICS | rezafungin acetate | Antibiotic |
CIRIUS THERAPEUTICS | azemiglitazone | Endocrinology |
CLOVIS ONCOLOGY | rociletinib | Oncology |
COHERUS BIOSCIENCES | pegfilgrastim-cbqv | Biologic Suffix |
COLUCID | lasmiditan | Neurology |
CONCERT PHARMACEUTICALS | deuruxolitinib | Dermatology |
CONCERT PHARMACEUTICALS | deuruxolitinib phosphate | Dermatology |
CONCERT PHARMACEUTICALS | deutivacaftor | Respiratory |
CONSTELLATION | lirametostat | Oncology |
CONSTELLATION | pelabresib | Oncology |
CONTRAFECT | exebacase | Antibiotic |
CONTRAVIR PHARMACEUTICALS | valnivudine | Antiviral |
CONTRAVIR PHARMACEUTICALS | tenofovir exalidex | Antiviral |
CORCEPT THERAPEUTICS | relacorilant | Metabolic Disorders |
CORCEPT THERAPEUTICS | miricorilant | Metabolic Disorders |
CORESTEM | lenzumestrocel | Neurology |
CORTENDO | levoketoconazole | Endocrinology |
CORVIDIA THERAPEUTICS | ziltivekimab | Nephrology |
CRINETICS | paltusotine | Endocrinology |
CYMABAY THERAPEUTICS | seladelpar lysine | Cardiovascular |
CYMABAY THERAPEUTICS | seladelpar | Cardiovascular |
CYTOCHROMA | lunacalcipol | Endocrinology |
CYTODYN | leronlimab | Antiviral/HIV |
CYTOMX THERAPEUTICS | pacmilimab | Oncology |
CYTOMX THERAPEUTICS | praluzatamab | Oncology |
CYTOMX THERAPEUTICS | praluzatamab ravtansine | Oncology |
D. WESTERN | cotosudil | Ophthalmology |
DAEWOONG PHARMACEUTICALS | enavogliflozin | Metabolic Disorders |
DAEWOONG PHARMACEUTICALS | prabotulinumtoxinA | Dermatology |
DAEWOONG PHARMACEUTICALS | fexuprazan | Gastrointestinal |
DAIICHI-SANKYO | datopotamab | Oncology |
DAIICHI-SANKYO | datopotamab deruxtecan | Oncology |
DAIICHI-SANKYO | obafistat | Cardiovascular |
DAIICHI-SANKYO | tivantinib | Oncology |
DAIICHI-SANKYO | patritumab | Oncology |
DAIICHI-SANKYO | milademetan | Oncology |
DAIICHI-SANKYO | firuglipel | Endocrinology |
DAIICHI-SANKYO | pexidartinib | Oncology |
DART NEUROSCIENCE | adarigiline | Neurology |
DECIPHERA PHARMACEUTICALS | vimseltinib | Oncology |
DENDREON | lapuleucel-t | Oncology |
DENDREON | sipuleucel-t | Oncology |
DERMA SCIENCES | aclerastide | Dermatology |
DERMIRA | olumacostat glasaretil | Dermatology |
DISCGENICS | rebonuputemcel | Neurology |
DNATRIX, INC. | tasadenoturev | Oncology |
DONG-A ST | velufenacin | Gastrointestinal |
DR. FALK PHARMA | norucholic acid | Metabolic Disorders |
DYAX | lanadelumab | Pain & Inflammation |
EA PHARMA | carotegrast | Immunology |
EA PHARMA | milategrast | Gastrointestinal |
EFFECTOR | zotatifin | Oncology |
EFFECTOR | tomivosertib | Oncology |
EIDOS THERAPEUTICS | acoramidis | Cardiovascular |
EISAI | amolimogene bepiplasmid | Antiviral |
EISAI | atopaxar | Cardiovascular |
EISAI | atopaxar hydrobromide | Cardiovascular |
EISAI | avatrombopag | Hematology |
EISAI | avatrombopag maleate | Hematology |
EISAI | lemborexant | Neurology |
EISAI | elenbecestat | Neurology |
ELOXX PHARMACEUTICALS | exaluren | Respiratory |
ELUSYS | obiltoxaximab | Immunology |
EMD SERONO | evobrutinib | Oncology |
ENANTA PHARMACEUTICALS | modithromycin | Antibiotic |
ENSTATIS | durlobactam | Antibiotic |
ENTEROME | sibofimloc | Gastrointestinal |
ENYO PHARMA | vonafexor | Metabolic Disorders |
ENZYCHEM | mosedipimod | Oncology |
ENZYMERX | pegadricase | Cardiovascular |
EPIZYME | tazemetostat | Oncology |
EPIZYME | pinometostat | Oncology |
ERIMOS PHARMACEUTICALS | terameprocol | Oncology |
ESPERION THERAPEUTICS | bempedoic acid | Cardiovascular |
EXELIXIS | cabozantinib | Oncology |
FERRING PHARMACEUTICALS | follitropin delta | Women's Health |
FERRING PHARMACEUTICALS | merotocin | Women's Health |
FERRING PHARMACEUTICALS | olamkicept | Immunology |
FERRING PHARMACEUTICALS | apraglutide | Metabolic Disorders |
FERRING PHARMACEUTICALS | velmupressin | Gastrointestinal |
FIBROGEN | pamrevlumab | Immunology |
FIBROGEN | roxadustat | Nephrology |
FIVE PRIME THERAPEUTICS | cabiralizumab | Oncology |
FIVE PRIME THERAPEUTICS | bemarituzumab | Oncology |
FIVE PRIME THERAPEUTICS | alsevalimab | Oncology |
FLEX PHARMA | enexasogaol | Neurology |
FORUM PHARMACEUTICALS | encenicline | Neurology |
FREQUENCY | laduviglusib | Neurology |
GAMAMABS | murlentamab | Oncology |
GENENTECH | mosunetuzumab | Oncology |
GENENTECH | tiragolumab | Oncology |
GENENTECH | cevostamab | Oncology |
GENENTECH | efmarodocokin alfa | Immunology |
GENENTECH | autogene cevumeran | Oncology |
GENENTECH | polatuzumab vedotin-piiq | Biologic Suffix |
GENENTECH | autogene cevumeran | Oncology |
GENENTECH | cobimetinib | Oncology |
GENENTECH | polatuzumab vedotin | Oncology |
GENENTECH | pinatuzumab vedotin | Oncology |
GENENTECH | ipatasertib | Oncology |
GENENTECH | lampalizumab | Ophthalmology |
GENENTECH | pateclizumab | Immunology |
GENENTECH | crenezumab | Neurology |
GENENTECH | quilizumab | Immunology |
GENENTECH | dulanermin | Oncology |
GENENTECH | rontalizumab | Immunology |
GENENTECH | oxelumab | Respiratory |
GENENTECH | etrolizumab | Immunology |
GENENTECH | emicizumab | Hematology |
GENENTECH | atezolizumab | Oncology |
GENENTECH | duligotuzumab | Oncology |
GENENTECH | taselisib | Oncology |
GENERON | efbemalenograstim alfa | Hematology |
GENERON | eflepedocokin alfa | Immunology |
GENERVON | alirinetide | Neurology |
GENEURO | temelimab | Neurology |
GENEXINE | efepoetin alfa | Hematology |
GENEXINE | eflenograstim alfa | Hematology |
GENEXINE | tirvalimogene teraplasmid | Oncology |
GENEXINE | efineptakin alfa | Oncology |
GENEXINE | eftansomatropin alfa | Metabolic Disorders |
GENFIT | elafibranor | Gastrointestinal |
GENORBIO | coprelotamab | Oncology |
GENORBIO | geptanolimab | Oncology |
GERON | paclitaxel trevatide | Oncology |
GILEAD | acalisib | Oncology |
GILEAD | ledipasvir | Antiviral |
GILEAD | vedroprevir | Antiviral |
GILEAD | entospletinib | Oncology |
GILEAD | sofosbuvir | Antiviral |
GILEAD | idelalisib | Oncology |
GILEAD | simtuzumab | Oncology |
GILEAD | nivocasan | Antiviral |
GILEAD | eleclazine | Cardiovascular |
GILEAD | tenofovir alafenamide | Antiviral/HIV |
GILEAD | velpatasvir | Antiviral/HIV |
GILEAD | radalbuvir | Antiviral |
GILEAD | presatovir | Respiratory |
GILEAD | vesatolimod | Oncology |
GILEAD | voxilaprevir | Antiviral |
GILEAD | bictegravir | Antiviral/HIV |
GILEAD | tirabrutinib | Oncology |
GILEAD | andecaliximab | Oncology |
GILEAD | remdesivir | Antiviral |
GILEAD | tilpisertib | Oncology |
GILEAD | lenacapavir | Antiviral |
GILEAD | lanraplenib | Immunology |
GILEAD | firsocostat | Metabolic Disorders |
GILEAD | cilofexor | Metabolic Disorders |
GILEAD | alobresib | Oncology |
GILEAD | sultimotide alfa | Immunology |
GILEAD | rovafovir etalafenamide | Antiviral |
GILEAD | magrolimab | Oncology |
GILEAD | elipovimab | Antiviral |
GILEAD | selgantolimod | Antiviral |
GLAXOSMITHKLINE | otilimab | Pain & Inflammation |
GLAXOSMITHKLINE | feladilimab | Oncology |
GLAXOSMITHKLINE | belantamab | Oncology |
GLAXOSMITHKLINE | belantamab mafodotin | Oncology |
GLAXOSMITHKLINE | linerixibat | Metabolic Disorders |
GLAXOSMITHKLINE | amlivirsen | Antiviral |
GLAXOSMITHKLINE | bepirovirsen | Antiviral |
GLAXOSMITHKLINE | depemokimab | Respiratory |
GLAXOSMITHKLINE | melrilimab | Respiratory |
GLAXOSMITHKLINE | pemrametostat | Oncology |
GLAXOSMITHKLINE | encelimab | Oncology |
GLAXOSMITHKLINE | molibresib | Oncology |
GLAXOSMITHKLINE | nemiralisib | Respiratory |
GLAXOSMITHKLINE | dezamizumab | Immunology |
GLAXOSMITHKLINE | miridesap | Immunology |
GLAXOSMITHKLINE | belizatinib | Oncology |
GLAXOSMITHKLINE | omipalisib | Oncology |
GLAXOSMITHKLINE | zastumotide | Oncology |
GLAXOSMITHKLINE | gepotidacin | Antibiotic |
GLAXOSMITHKLINE | lanopepden | Antibiotic |
GLAXOSMITHKLINE | uprosertib | Oncology |
GLAXOSMITHKLINE | albiglutide | Endocrinology |
GLAXOSMITHKLINE | astuprotimut-r | Oncology |
GLAXOSMITHKLINE | gabapentin enacarbil | Neurology |
GLAXOSMITHKLINE | sergliflozin | Endocrinology |
GLAXOSMITHKLINE | sodelglitazar | Endocrinology |
GLAXOSMITHKLINE | raxibacumab | Antibiotic |
GLENMARK PHARMACEUTICALS | telazorlimab | Oncology |
GLOBAL BLOOD THERAPEUTICS | voxelotor | Hematology |
GLYCOTOPE | timigutuzumab | Oncology |
GLYCOTOPE | tomuzotuximab | Oncology |
GLYCOTOPE | gatipotuzumab | Oncology |
GLYCOTOPE | follitropin epsilon | Women's Health |
GNT PHARMA | nelonemdaz | Cardiovascular |
GNT PHARMA | crisdesalazine | Neurology |
GOSSAMER BIO | pexopiprant | Respiratory |
GOSSAMER BIO | seralutinib | Cardiovascular |
GREEN CROSS | lenvervimab | Antiviral |
GRUNENTHAL | lexanopadol | Pain & Inflammation |
GRUNENTHAL | cebranopadol | Pain & Inflammation |
GTREEBNT | timbetasin | Ophthalmology |
GTX | enobosarm | Musculoskeletal |
HALOZYME THERAPEUTICS | pegvorhyaluronidase alfa | Oncology |
HANALL BIOPHARMA | tafanercept | Ophthalmology |
HANALL BIOPHARMA | batoclimab | Immunology |
HANMI PHARMACEUTICALS | belvarafenib | Oncology |
HANMI PHARMACEUTICALS | poseltinib | Oncology |
HANMI PHARMACEUTICALS | olmutinib | Oncology |
HATCHTECH | abametapir | Dermatology |
HORIZON THERAPEUTICS | teprotumumab-trbw | Biologic Suffix |
HOSPIRA | epoetin alfa-epbx | Biologic Suffix |
HOSPIRA | filgrastim-aafi | Biologic Suffix |
HUA MEDICINE | dorzagliatin | Endocrinology |
HUMANIGEN | ifabotuzumab | Pain & Inflammation |
HUMANIGEN | rivabazumab | Immunology |
HUMANIGEN | rivabazumab pegol | Immunology |
HUMANIGEN | lenzilumab | Respiratory |
IDEAYA BIOSCIENCES | darovasertib | Oncology |
IDERA PHARMACEUTICALS | tilsotolimod | Oncology |
IGNYTA | entrectinib | Oncology |
IMARA | tovinontrine | Hematology |
IMMUNOGEN | mirvetuximab soravtansine | Oncology |
IMMUNOGEN | laprituximab | Oncology |
IMMUNOGEN | laprituximab emtansine | Oncology |
IMMUNOGEN | naratuximab emtansine | Oncology |
IMMUNOGEN | cantuzumab ravtansine | Oncology |
IMMUNOGEN | lorvotuzumab mertansine | Oncology |
IMMUNOGENX | latiglutenase | Gastrointestinal |
INCYTE | pemigatinib | Oncology |
INNOCRIN PHARMACEUTICALS | seviteronel | Oncology |
INOVIO | mavilimogene ralaplasmid | Oncology |
INOVIO | bizalimogene ralaplasmid | Oncology |
INSMED | treprostinil palmitil | Cardiovascular |
INSMED | brensocatib | Respiratory |
INSPYR THERAPEUTICS | mipsagargin | Oncology |
INTENDIS | mapracorat | Dermatology |
INTRA-CELLULAR THERAPIES | lumateperone | Neurology |
INTRA-CELLULAR THERAPIES | lumateperone tosylate | Neurology |
INTREXON | veledimex | Oncology |
INTRON BIOTECHNOLOGY | tonabacase | Antibiotic |
INVENTIVA PHARMA | lanifibranor | Gastrointestinal |
IOVANCE BIOTHERAPEUTICS | lifileucel | Oncology |
IPSEN BIOPHARM LTD | satoreotide tetraxetan | Oncology |
IPSEN BIOPHARM LTD | zalsenertant tetraxetan | Oncology |
IRONWOOD | olinciguat | Cardiovascular |
IRONWOOD | praliciguat | Cardiovascular |
IRONWOOD | linaclotide | Gastrointestinal |
IRONWOOD | recanaclotide | Gastrointestinal |
ISOFOL | arfolitixorin | Oncology |
ISU ABXIS | barecetamab | Oncology |
JANSSEN | daplusiran | Antiviral |
JANSSEN | onametostat | Oncology |
JANSSEN | amivantamab | Oncology |
JANSSEN | tesnatilimab | Gastrointestinal |
JANSSEN | rilematovir | Antiviral |
JANSSEN | lorpucitinib | Oncology |
JANSSEN | lazertinib | Oncology |
JANSSEN | talquetamab | Oncology |
JANSSEN | adafosbuvir | Antiviral |
JANSSEN | atabecestat | Neurology |
JANSSEN | opolimogene capmilisbac | Oncology |
JANSSEN | pemlimogene merolisbac | Oncology |
JANSSEN | talacotuzumab | Oncology |
JANSSEN | efinopegdutide | Obesity |
JANSSEN | edicotinib | Immunology |
JANSSEN | cetrelimab | Oncology |
JANSSEN | onvatilimab | Oncology |
JANSSEN | mitazalimab | Oncology |
JANSSEN | bersacapavir | Antiviral |
JANSSEN | ciltacabtagene autoleucel | Oncology |
JANSSEN | teclistamab | Oncology |
JANSSEN | duvortuxizumab | Oncology |
JANSSEN | apalutamide | Oncology |
JANSSEN | palucorcel | Ophthalmology |
JANSSEN | pimodivir | Antiviral |
JANSSEN | lumicitabine | Antiviral |
JANSSEN | seltorexant | Oncology |
JANSSEN | daratumumab | Oncology |
JANSSEN | esketamine hydrochloride | Neurology |
JANSSEN | guselkumab | Pain & Inflammation |
JANSSEN | ustekinumab | Immunology |
JAPAN TOBACCO | delgocitinib | Dermatology |
JAPAN TOBACCO | enarodustat | Hematology |
JAZZ PHARMACEUTICALS | elpetrigine | Neurology |
JAZZ PHARMACEUTICALS | solriamfetol | Neurology |
JAZZ PHARMACEUTICALS | pegcrisantaspase | Oncology |
JOHNSON & JOHNSON | mibenratide | Cardiovascular |
JOHNSON & JOHNSON | diridavumab | Antiviral/HIV |
JOHNSON & JOHNSON | arhalofenate | Endocrinology |
JOHNSON & JOHNSON | canagliflozin | Endocrinology |
JOHNSON & JOHNSON | carisbamate | Neurology |
JOHNSON & JOHNSON | intetumumab | Oncology |
JOHNSON & JOHNSON | rilpivirine | Antiviral/HIV |
JOHNSON & JOHNSON | senicapoc | Hematology |
JOHNSON & JOHNSON | serdemetan | Oncology |
JOHNSON & JOHNSON | siltuximab | Oncology |
JOHNSON & JOHNSON | talmapimod | Oncology |
JOHNSON & JOHNSON | ustekinumab | Immunology |
JOHNSON & JOHNSON | fulranumab | Pain & Inflammation |
JOHNSON & JOHNSON | bavisant | Neurology |
JOHNSON & JOHNSON | carlumab | Oncology |
JOHNSON & JOHNSON | mavatrep | Pain & Inflammation |
JOHNSON & JOHNSON | usistapide | Endocrinology |
JOHNSON & JOHNSON | simeprevir | Antiviral |
JOHNSON & JOHNSON | sirukumab | Immunology |
JOHNSON & JOHNSON | evabotulinumtoxina | Neurology |
JOHNSON & JOHNSON | quisinostat | Oncology |
JOUNCE | vopratelimab | Oncology |
JOUNCE | pimivalimab | Oncology |
JW PHARMACEUTICAL | relmacabtagene autoleucel | Oncology |
JW PHARMACEUTICAL | epaminurad | Nephrology |
JW THERAPEUTICS | lisocabtagene maraleucel | Oncology |
KADMON | belumosudil | Immunology |
KADMON | belumosudil mesylate | Immunology |
KANDY THERAPEUTICS | elinzanetant | Women's Health |
KARYOPHARM | selinexor | Oncology |
KARYOPHARM | verdinexor | Animal Health |
KARYOPHARM | eltanexor | Musculoskeletal |
KHONDRION | sonlicromanol | Cardiovascular |
KINETA | dalazatide | Immunology |
KISSEI | mizagliflozin | Gastrointestinal |
KISSEI | linzagolix | Women's Health |
KOWA PHARMACEUTICALS | pemafibrate | Cardiovascular |
KOWA PHARMACEUTICALS | ripasudil | Ophthalmology |
LEADIANT BIOSCI | elapegademase-lvlr | Biologic Suffix |
LEADIANT BIOSCIENCES | elapegademase | Immunology |
LEGOCHEM | delpazolid燑/td> | Antibiotic |
LEO PHARMA | orismilast | Dermatology |
LIB THERAPEUTICS | lerodalcibep | Cardiovascular |
LIMINAL BIOSCIENCES | fezagepras | Immunology |
LIN BIOSCIENCE | tinlarebant | Ophthalmology |
LOGICAL THERAPEUTICS | naproxen etemesil | Pain & Inflammation |
LOXO ONCOLOGY | larotrectinib | Oncology |
LOXO ONCOLOGY | selitrectinib | Oncology |
LOXO ONCOLOGY | selpercatinib | Oncology |
LSK BIOPHARMA | rivoceranib | Oncology |
LUNDBECK | eptinezumab | Pain & Inflammation |
LUNDBECK | ingenol disoxate | Oncology |
LUNDBECK | idalopirdine | Neurology |
LUNDBECK | vortioxetine | Neurology |
LUNDBECK | tedatioxetine | Neurology |
LYCERA | parimifasor | Pain & Inflammation |
LYCERA | cintirorgon | Oncology |
LYSOGENE | olenasufligene relduparvovec | Metabolic Disorders |
LYTIX BIOPHARMA | ruxotemitide | Oncology |
MADRIGAL | resmetirom | Metabolic Disorders |
MARKER THERAPEUTICS | zedenoleucel | Oncology |
MAST THERAPEUTICS | folitixorin | Oncology |
MAST THERAPEUTICS | folitixorin calcium | Oncology |
MEDEOR THERAPEUTICS | firzotemcel | Nephrology |
MEDEOR THERAPEUTICS | sizavaluecel | Nephrology |
MEDIBEACON | relmapirazin | Nephrology |
MEDIMMUNE | efgivanermin alfa | Oncology |
MEDIMMUNE | blinatumomab | Oncology |
MEDIMMUNE | etaracizumab | Oncology |
MEDIMMUNE | benralizumab | Immunology |
MEDIMMUNE | mavrilimumab | Immunology |
MEDIMMUNE | moxetumomab pasudotox | Oncology |
MEDIMMUNE | tralokinumab | Immunology |
MEDIPOST | tenvumestrocel | Pain & Inflammation |
MEI PHARMA | zandelisib | Oncology |
MERCK & CO. | baloramotide | Oncology |
MERCK & CO. | cadalimogene ixalentivec | Oncology |
MERCK & CO. | lapretolimod | Oncology |
MERCK & CO. | belzutifan | Oncology |
MERCK & CO. | vorapaxar sulfate | Cardiovascular |
MERCK & CO. | tedizolid | Antibiotic |
MERCK & CO. | surotomycin | Antibiotic |
MERCK & CO. | pembrolizumab | Oncology |
MEREO BIOPHARM | ipafricept | Oncology |
MEREO BIOPHARM | tarextumab | Oncology |
MEREO BIOPHARM | vantictumab | Oncology |
MEREO BIOPHARM | demcizumab | Oncology |
MEREO BIOPHARM | navicixizumab | Oncology |
MEREO BIOPHARM | brontictuzumab | Oncology |
MEREO BIOPHARM | rosmantuzumab | Oncology |
MEREO BIOPHARM | navicixizumab | Oncology |
MEREO BIOPHARM | efaprinermin alfa | Oncology |
MEREO BIOPHARM | etigilimab | Oncology |
MERUS | zenocutuzumab | Oncology |
MICROBION | pravibismane | Antibiotic |
MILESTONE PHARMACEUTICALS | etripamil | Cardiovascular |
MILLENDO | livoletide | Metabolic Disorders |
MINORYX | leriglitazone | Neurology |
MIRATI THERAPEUTICS | glesatinib | Oncology |
MIRATI THERAPEUTICS | sitravatinib | Oncology |
MIRATI THERAPEUTICS | mocetinostat | Oncology |
MIRATI THERAPEUTICS | mocetinostat dihydrobromide | Oncology |
MITSUBISHI TANABE | amiselimod | Immunology |
MITSUBISHI TANABE | elismetrep | Neurology |
MOLOGEN | lefitolimod | Oncology |
MONOPAR | camsirubicin | Oncology |
MORPHOSYS | tafasitamab | Oncology |
MORPHOSYS | felzartamab | Oncology |
MUNDIPHARMA | tinostamustine | Oncology |
MYRIAD | verubulin | Oncology |
NANOCARRIER | demplatin pegraglumer | Oncology |
NEKTAR | bempegaldesleukin | Oncology |
NEKTAR | oxycodegol | Pain & Inflammation |
NEKTAR | avipendekin pegol | Oncology |
NEKTAR | etirinotecan pegol | Oncology |
NEKTAR | etirinotecan pegol tetrahydrochloride | Oncology |
NEKTAR | etirinotecan pegol tetratriflutate | Oncology |
NEKTAR | naloxegol | Gastrointestinal |
NEOGENIX ONCOLOGY | ensituximab | Oncology |
NEUREN | trofinetide | Neurology |
NEUROCRINE BIOSCIENCES | crinecerfont | Neurology |
NEUROSEARCH | pridopidine | Neurology |
NEUROTECH | evagenretcel | Ophthalmology |
NGM BIOPHARMACEUTICALS | aldafermin | Metabolic Disorders |
NIPPON KAYAKU | firtecan peglumer | Oncology |
NONO | nerinetide | Cardiovascular |
NOVAN | berdazimer sodium | Dermatology |
NOVARTIS | tisagenlecleucel | Oncology |
NOVARTIS | crizanlizumab-tmca | Biologic Suffix |
NOVARTIS | brolucizumab-dbll | Biologic Suffix |
NOVARTIS | sacubitril | Cardiovascular |
NOVARTIS | lucatumumab | Oncology |
NOVARTIS | dovitinib | Oncology |
NOVARTIS | dovitinib lactate | Oncology |
NOVARTIS | crizanlizumab | Hematology |
NOVARTIS | branaplam | Neurology |
NOVO NORDISK | somapacitan | Metabolic Disorders |
NOVO NORDISK | insulin degludec | Endocrinology |
NOVO NORDISK | fletikumab | Immunology |
NUCANA | fosgemcitabine palabenamide | Oncology |
NUCANA | fosifloxuridine nafalbenamide | Oncology |
OBI PHARMA | adagloxad simolenin | Immunology |
OCTAPHARMA | immune globulin intravenous, human-ifas | Biologic Suffix |
OCTREOPHARM | satoreotide trizoxetan | Oncology |
OLATEC | dapansutrile | Pain & Inflammation |
ONCOPEPTIDES | melphalan flufenamide | Oncology |
ONCOSEC | tavokinogene telseplasmid | Oncology |
ONCOTHERAPY SCIENCE | latromotide | Oncology |
ONCOTHERAPY SCIENCE | pradimotide | Oncology |
ONCOTHERAPY SCIENCE | elpamotide | Oncology |
ONCOTHERAPYSCIENCE | tabituximab | Oncology |
ONCOTHERAPYSCIENCE | tabituximab barzuxetan | Oncology |
ONO PHARMACEUTICALS | ceralifimod | immunology |
ONXEO | etidaligide | Oncology |
OPEXA THERAPEUTICS | imilecleucel-t | Immunology |
ORCHARD THERAPEUTICS | atidarsagene autotemcel | Hematology |
ORIGIN BIOSCIENCES | fosdenopterine | Metabolic Disorders |
ORION PHARMA | neluxicapone | Neurology |
ORION PHARMA ANIMAL HEALTH | tasipimidine | Animal Health |
ORPHAN TECHNOLOGIES | pegtibatinase | Metabolic Disorders |
OSCOTEC | cevidoplenib | Immunology |
OSI PHARMACEUTICALS | linsitinib | Oncology |
OTSUKA PHARMACEUTICAL | tolvaptan | Nephrology |
OTSUKA PHARMACEUTICAL | brexpiprazole | Neurology |
OUTPOST MEDICINE | pregabalin arenacarbil | Gastrointestinal |
OXIGENE | fosbretabulin | Oncology |
OXIGENE | fosbretabulin disodium | Oncology |
OXIGENE | fosbretabulin tromethamine | Oncology |
PFIZER | latrepirdine | Neurology |
PFIZER | latrepirdine | Neurology |
PFIZER | agatolimod | Oncology |
PFIZER | eribaxaban | Hematology |
PFIZER | taprenepag | Ophthalmology |
PFIZER | tofacitinib | Immunology |
PFIZER | enzalutamide | Oncology |
PFIZER | cindunistat | Pain & Inflammation |
PFIZER | rivipansel | Hematology |
PFIZER | rivipansel sodium | Hematology |
PFIZER | talazoparib | Oncology |
PFIZER | fosdagrocorat | Pain & Inflammation |
PFIZER | epetraborole | Antibiotic |
PFIZER | crisaborole | Dermatology |
PFIZER | dagrocorat | Pain & Inflammation |
PFIZER | gemtuzumab ozogamicin | Oncology |
PFIZER | acoziborole | Antibiotic |
PFIZER | fidanacogene elaparvovec | Hematology |
PFIZER | elranatamab | Oncology |
PFIZER | ropsacitinib | Pain & Inflammation |
PFIZER | tozinameran | Antiviral |
PFIZER | fidanacogene elaparvovec | Hematology |
PFIZER | trastuzumab-qyyp | Biologic Suffix |
PFIZER | bevacizumab-bvzr | Biologic Suffix |
PFIZER | rituximab-pvvr | Biologic Suffix |
PFIZER | adalimumab-afzb | Biologic Suffix |
PFIZER | infliximab-qbtx | Biologic Suffix |
PFIZER | recifercept | Musculoskeletal |
PH PHARMA | sovesudil | Ophthalmology |
PHARMACYCLICS | ibrutinib | Oncology |
PHARMACYCLICS | abexinostat | Oncology |
PHARMAZZ | sovateltide | Cardiovascular |
PHARMAZZ | centhaquine | Hematology |
PHOSPLATIN THERAPEUTICS | imifoplatin | Oncology |
PIERIS PHARMACEUTICALS | cinrebafusp alfa | Oncology |
PIQUR | bimiralisib | Oncology |
PLURISTEM THERAPEUTICS | emiplacel | Cardiovascular |
PRECISION BIOSCIENCES | azercabtagene zapreleucel | Immunology |
PRINCIPIA BIOPHARMA | rilzabrutinib | Pain & Inflammation |
PRINCIPIA BIOPHARMA | rilzabrutinib | Pain & Inflammation |
PROMETHEUS | prednisolone sodium metazoate | Gastrointestinal |
PROTALEX | bevifimod | Immunology |
PROTHENA | birtamimab | Immunology |
PROTHENA | imaprelimab | Immunology |
QLT USA | zuretinol acetate | Ophthalmology |
QUANTUM GENOMICS | firibastat | Cardiovascular |
QUARK PHARMACEUTICALS | cosdosiran | Ophthalmology |
QUARK PHARMACEUTICALS | teprasiran | Nephrology |
QURIENT | telacebec | Respiratory |
RA | zilucoplan | Hematology |
RADIUS HEALTH | vosilasarm | Oncology |
RADIUS HEALTH | elacestrant | Oncology |
RADIUS HEALTH | abaloparatide | women's health |
RAFAEL PHARMACEUTICALS | devimistat | Oncology |
RALEXAR | rovazolac | Dermatology |
RBIO | atleradstrocel | Pain & Inflammation |
REATA PHARMACEUTICALS | bardoxolone methyl | Cardiovascular |
REATA PHARMACEUTICALS | omaveloxolone | Neurology |
RECEPTOS | ozanimod | Immunology |
REGENERON PHARMACEUTICALS | itepekimab | Respiratory |
RELYPSA | patiromer sorbitex calcium | Nephrology |
REMD BIOTHERAPEUTICS | volagidemab | Metabolic Disorders |
REMD BIOTHERAPEUTICS | volagidemab | Metabolic Disorders |
REPLIDYNE | bederocin | Antibiotic |
RESVERLOGIX | apabetalone | Cardiovascular |
REVIVA | brilaroxazine | Neurology |
ROCHE | simlukafusp alfa | Immunology |
ROCHE | ralmitaront | Neurology |
ROCHE | tominersen | Neurology |
ROCHE | imgatuzumab | Oncology |
ROCHE | palovarotene | Respiratory |
ROCHE | taspoglutide | Endocrinology |
ROCHE | emicizumab | Hematology |
SAGE THERAPEUTICS | zuranolone | Neurology |
SALARIUS | seclidemstat | Oncology |
SALIX PHARMACEUTICALS | rifamycin sodium | Antibiotic |
SAMUMED | lorecivivint | Pain & Inflammation |
SAMUMED | cirtuvivint | Oncology |
SAMUMED | dalosirvat | Immunology |
SAMUMED | ipivivint | Respiratory |
SAMUMED | teplinovivint | Pain & Inflammation |
SAMUS | icapamespib | Neurology |
SAMUS | zelavespib | Neurology |
SANDOZ | pegfilgrastim- bmez | Biologic Suffix |
SANDOZ | adalimumab-adaz | Biologic Suffix |
SANDOZ | etanercept-szzs | Biologic Suffix |
SANGAMO THERAPEUTICS | adlinacogene civaparvovec | Hematology |
SANGAMO THERAPEUTICS | devafidugene civaparvovec | Metabolic Disorders |
SANGAMO THERAPEUTICS | inlezifigene civaparvovec | Hematology |
SANGAMO THERAPEUTICS | ranuzifigene civaparvovec | Hematology |
SANGAMO THERAPEUTICS | tefidsogene civaparvovec | Metabolic Disorders |
SANOFI | amcenestrant | Oncology |
SANOFI | amcenestrant | Oncology |
SANOFI | volinanserin | Neurology |
SANOFI | fedratinib | Oncology |
SANOFI | pilaralisib | Oncology |
SANOFI | seribantumab | Oncology |
SANOFI | voxtalisib | Oncology |
SANOFI | isatuximab | Oncology |
SANOFI GENZYME | fresolimumab | Immunology |
SANOFI GENZYME | tolebrutinib | Neurology |
SANOFI GENZYME | gatralimab | Oncology |
SANOFI GENZYME | romilkimab | Respiratory |
SANTHERA PHARMACEUTICALS | lonodelestat | Respiratory |
SANWA KAGAKU | lazuvapagon | Neurology |
SAREPTA THERAPEUTICS | eteplirsen | Musculoskeletal |
SAREPTA THERAPEUTICS | radavirsen | Antiviral |
SAREPTA THERAPEUTICS | golodirsen | Neurology |
SCM LIFESCIENCE | mocemestrocel | Immunology |
SCYNEXIS | ibrexafungerp | Antifungal |
SEATTLE GENETICS | ladiratuzumab | Oncology |
SEATTLE GENETICS | ladiratuzumab vedotin | Oncology |
SEATTLE GENETICS | denintuzumab mafodotin | Oncology |
SEATTLE GENETICS | tucatinib | Oncology |
SEATTLE GENETICS | vadastuximab talirine | Oncology |
SEATTLE GENETICS | vadastuximab | Oncology |
SEATTLE GENETICS | sonolisib | Oncology |
SEATTLE GENETICS | vorsetuzumab mafodotin | Oncology |
SEATTLE GENETICS | enfortumab vedotin | Oncology |
SEIKAGAKU | condoliase | Musculoskeletal |
SEIKAGAKU | cinhyaluronate sodium | Ophthalmology |
SEIKAGAKU | diclofenac etalhyaluronate | Pain & Inflammation |
SENSORION | seliforant | Neurology |
SENSORION | arazasetron | Neurology |
SHINPOONG | otaplimastat | Cardiovascular |
SHIONOGI PHARMA | redasemtide | Dermatology |
SHIONOGI PHARMA | sivopixant | Neurology |
SHIONOGI PHARMA | alicdamotide | Oncology |
SHIONOGI PHARMA | epertinib | Oncology |
SHIONOGI PHARMA | naldemedine | Gastrointestinal |
SHIONOGI PHARMA | asudemotide | Oncology |
SHIONOGI PHARMA | trempamotide | Oncology |
SHIONOGI PHARMA | asapiprant | Respiratory |
SHIONOGI PHARMA | rovatirelin | Neurology |
SHIONOGI PHARMA | lusutrombopag | Cardiovascular |
SHIONOGI PHARMA | velneperit | Obesity |
SIEMENS | flortanidazole (18f) | Oncology |
SIEMENS | flotegatide (18f) | Oncology |
SILLAJEN | pexastimogene devacirepvec | Oncology |
SK LIFE SCIENCE | cenobamate | Neurology |
SK LIFE SCIENCE | relenopride | Gastrointestinal |
SOBI | emapalumab | Hematology |
SOLID BIOSCIENCES | zildistrogene varoparvovec | Musculoskeletal |
SPARC | vodobatinib | Oncology |
SPECTRUM PHARMACEUTICALS | belinostat | Oncology |
SPRING BANK | inarigivir soproxil | Antiviral |
SPRUCE | tildacerfont | Endocrinology |
STEALTH BIOTHERAPEUTICS | elamipretide | Cardiovascular |
STEMLINE THERAPEUTICS | felezonexor | Oncology |
STIEFEL LABORATORIES | tapinarof | Dermatology |
SUCAMPO PHARMA | nobiprostolan | Dermatology |
SUMITOMO DAINIPPON PHARMA | afacifenacin | Urology |
SUMITOMO DAINIPPON PHARMA | minesapride | Gastrointestinal |
SUNESIS PHARMACEUTICALS | vecabrutinib | Oncology |
SUNESIS PHARMACEUTICALS | vosaroxin | Oncology |
SUNOVION | dasotraline | Neurology |
SUNOVION | vandefitemcel | Cardiovascular |
SUNOVION | aramisulpride | Neurology |
SUNOVION | esamisulpride | Neurology |
SUNOVION | aramisulpride | Neurology |
SURFACE ONCOLOGY | urabrelimab | Oncology |
SYMPHOGEN | rozrolimupab | Immunology |
SYNDAX | axatilimab | Oncology |
SYNTA PHARMACEUTICALS | elesclomol | Oncology |
SYNTA PHARMACEUTICALS | rosabulin | Oncology |
SYNTIMMUNE | orilanolimab | Immunology |
SYNTRIX BIO | desmetramadol | Pain & Inflammation |
SYROS | mevociclib | Oncology |
TAIRX | foslinanib | Oncology |
TAISHO PHARMACEUTICAL | setafrastat | Endocrinology |
TAKARA BIO | canerpaturev | Oncology |
TAKARA BIO | mipetresgene autoleucel | Oncology |
TAKARA BIO | tebrocabtagene autoleucel | Oncology |
TAKEDA | mobocertinib | Oncology |
TAKEDA | lomardexafetamine | Neurology |
TAKEDA | mezagitamab | Immunology |
TAKEDA | trazpiroben | Gastrointestinal |
TAKEDA | felcisetrag | Gastrointestinal |
TAKEDA | danavorexton | Neurology |
TAKEDA | firazorexton | Neurology |
TAKEDA | suntinorexton | Neurology |
TAKEDA | apadamtase alfa | Hematology |
TAKEDA | valziflocept | Immunology |
TAKEDA | valanafusp alfa | Metabolic Disorders |
TAKEDA | ontamalimab | Gastrointestinal |
TAKEDA | mivavotinib | Oncology |
TAKEDA | soticlestat | Neurology |
TAKEDA | simurosertib | Oncology |
TAKEDA | alogliptin | Endocrinology |
TAKEDA | alogliptin benzoate | Endocrinology |
TAKEDA | azilsartan | Cardiovascular |
TAKEDA | azilsartan kamedoxomil | Cardiovascular |
TAKEDA | azilsartan medoxomil | Cardiovascular |
TAKEDA | lapaquistat | Cardiovascular |
TAKEDA | lapaquistat acetate | Cardiovascular |
TAKEDA | namilumab | Immunology |
TAKEDA | orteronel | Oncology |
TAKEDA | ixazomib | Oncology |
TAKEDA | alisertib | Oncology |
TAKEDA | vonicog alfa | Hematology |
TAKEDA | nonacog gamma | Hematology |
TAKEDA | revexepride | Gastrointestinal |
TAKEDA | fasiglifam | Endocrinology |
TAKEDA | relugolix | Women's Health |
TAKEDA | trelagliptin | Endocrinology |
TAKEDA | rafigrelide | Cardiovascular |
TAKEDA | vonoprazan | Gastrointestinal |
TAKEDA | serabelisib | Oncology |
TAKEDA | maralixibat chloride | Metabolic Disorders |
TAKEDA | imarikiren | Cardiovascular |
TAKEDA | balipodect | Neurology |
TAKEDA | plozalizumab | Immunology |
TAKEDA | rurioctocog alfa pegol | Hematology |
TAKEDA | imalumab | Oncology |
TAKEDA | sapanisertib | Oncology |
TAKEDA | susoctocog alfa | Hematology |
TAKEDA | indusatumab | Oncology |
TAKEDA | indusatumab vedotin | Oncology |
TB ALLIANCE | pretomanid | Respiratory |
TELIX PHARMACEUTICALS | rosopatamab | Oncology |
TELIX PHARMACEUTICALS | rosopatamab tetraxetan | Oncology |
TEVA PHARMACEUTICAL INDUSTRIES | albusomatropin | Metabolic Disorders |
TEVA PHARMACEUTICALS INDUSTRIES | omacetaxine mepesuccinate | Oncology |
THERAVANCE | velusetrag | Gastrointestinal |
THERAVANCE | velusetrag hydrochloride | Gastrointestinal |
THERAVANCE | axelopran | Gastrointestinal |
THERAVANCE | cefilavancin | Antibiotic |
THERAVANCE | revefenacin | Respiratory |
THERAVANCE | ampreloxetine | Neurology |
THRESHOLD PHARMACEUTICALS | tarloxotinib bromide | Oncology |
THROMBOGENICS | ocriplasmin | Cardiovascular |
TISSUEGENE | tonogenchoncel-l | Pain & Inflammation |
TISSUEGENE | tonogenconcel | Pain & Inflammation |
TOPICA PHARMACEUTICALS | luliconazole | Antifungal |
TORAY | esuberaprost | Cardiovascular |
TORAY | esuberaprost sodium | Cardiovascular |
TORAY | beraprost | Cardiovascular |
TORAY | naltalimide | Urology |
TOYAMA CHEMICAL | edonerpic | Neurology |
TRACON PHARMACEUTICALS | carotuximab | Oncology |
TRANSLATE BIO | pomulmeran | Respiratory |
TRUE NORTH | sutimlimab | Immunology |
TYROGENEX | vorolanib | Oncology |
UBE INDUSTRIES | omidenepag | Ophthalmology |
UCB | seletalisib | Immunology |
UCB | padsevonil | Neurology |
UCB | dapirolizumab pegol | Immunology |
UCB | abrezekimab | Respiratory |
UCB | zampilimab | Pain & Inflammation |
UCB | bepranemab | Neurology |
ULTRAGENYX PHARMACEUTICAL | triheptanoin | Metabolic Disorders |
ULTRAGENYX PHARMACEUTICAL | pariglasgene brecaparvovec | Endocrinology |
ULTRAGENYX PHARMACEUTICAL | avalotcagene ontaparvovec | Metabolic Disorders |
UNIQURE BIOPHARMA | etranacogene dezaparvovec | Hematology |
UNIQURE BIOPHARMA | lanacogene vosiparvovec | Hematology |
VALERION THERAPEUTICS | clervonafusp alfa | Metabolic Disorders |
VANDA PHARMACEUTICALS | tradipitant | Dermatology |
VANTIA THERAPEUTICS | fedovapagon | Urology |
VASOPHARM | ronopterin | Neurology |
VENATORX | taniborbactam | Antibiotic |
VERICEL | ixmyelocel-t | Cardiovascular |
VERONA PHARMA | ensifentrine | Respiratory |
VERSARTIS | somavaratan | Metabolic Disorders |
VERTEX PHARMACEUTICALS | tezacaftor | Respiratory |
VERTEX PHARMACEUTICALS | berzosertib | Oncology |
VIAMET PHARMACEUTICALS | oteseconazole | Antifungal |
VIAMET PHARMACEUTICALS | quilseconazole | Antibiotic |
VIDAC PHARMA | tuvatexib | Dermatology |
VIFOR PHARMA | vamifeport | Endocrinology |
VION | laromustine | Oncology |
VIROMED | donaperminogene seltoplasmid | Cardiovascular |
VOYAGER THERAPEUTICS | ezaladcigene resoparvovec | Neurology |
VTV THERAPEUTICS | azeliragon | Neurology |
WAVE LIFE SCIENCES | suvodirsen | Neurology |
WAVE LIFE SCIENCES | suvodirsen | Musculoskeletal |
WAVE LIFE SCIENCES | suvodirsen sodium | Musculoskeletal |
WEX PHARMACEUTICALS | tetrodotoxin | Pain & Inflammation |
X4 | mavorixafor | Oncology |
XCOVERY | ensartinib | Oncology |
XOMA | gevokizumab | Immunology |
YM BIOSCIENCES | momelotinib | Hematology |
YM BIOSCIENCES | lexibulin | Oncology |
ZAFGEN | aclimostat | Obesity |
ZAFGEN | relzomostat | Neurology |
ZEALAND PHARMA | dasiglucagon | Endocrinology |
ZEALAND PHARMA | glepaglutide | Gastrointestinal |
ZYMEWORKS | zanidatamab zovodotin | Oncology |
ZYMEWORKS | zanidatamab | Oncology |